NOVA BIOMEDICAL

Nova Biomedical develops, manufactures, and sells advanced technology blood testing analyzers. We employ over 1,400 people, with sales and service subsidiaries in eight countries and distributors in more than 91 additional countries. Nova has manufacturing facilities in Waltham and Billerica, Massachusetts; and Taipei, Taiwan. Nova is one of the 25 largest in vitro diagnostic companies in the world and the largest privately owned in vitro diagnostic company in the United States... In addition to Nova products, we develop and manufacture medical devices and diagnostic products for many of the world's leading healthcare corporations... Nova manufactures a series of BioProfile® automated cell culture analyzers for rapid analysis of key nutrients, metabolites, pH, gases, and cell density/cell viability.

Also known as: Nova, Nova Biomedical ANZ Pty. Ltd., Nova Biomedical Benelux B.V., Nova Biomedical Brasil, Nova Biomedical Canada, Ltd, NOVA BIOMEDICAL CORPORATION, Nova Biomedical France, Nova Biomedical GmbH, Nova Biomedical Iberia, S.L., Nova Biomedical Italia S.r.l., Nova Biomedical K.K., Nova Biomedical Schweiz GmbH, Nova Biomedical U.K.

Registration numbers: FC022653 (CH)

Primary location: Walldorf Germany